Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Current Deferred Tax Assets (2009 - 2026)

Updated

Bristol Myers Squibb's Current Deferred Tax Assets was $1.73 billion in Q3 2015, up 14.6% from $1.51 billion a year earlier but down 8.5% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Current Deferred Tax Assets (2009 - 2026) Analysis & Trends

At the end of FY2014, Current Deferred Tax Assets at Bristol Myers Squibb came in at $1.64 billion, down 3.4% from FY2013.

  • Current Deferred Tax Assets shows a five-year compound annual growth rate of 21.9% (FY2009 to FY2014).
  • In earlier years, Current Deferred Tax Assets was $1.7 billion in FY2013 (+6.5%), $1.6 billion in FY2012 (+33.1%), $1.2 billion in FY2011 (+15.8%) and $1.04 billion in FY2010 (+69.6%).
  • Quarterly Current Deferred Tax Assets has moved between $1.04 billion (Q4 2010) and $2.04 billion (Q3 2013) over five years.
  • Compared with a year earlier, Current Deferred Tax Assets has increased for three straight quarters, with growth averaging 1.5% over the last eight quarters.
  • The best year-over-year quarter for Current Deferred Tax Assets over five years was Q4 2010 (growth of 69.6%); the worst was Q2 2014 (a decline of 30.8%).
  • Per Business Quant data, BMY's Current Deferred Tax Assets in the three quarters before Q3 2015 was $1.89 billion (Q2 2015), $1.89 billion (Q1 2015) and $1.64 billion (Q4 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 228.00 Mn
Jun 30, 2026 222.00 Mn
Mar 31, 2026 211.00 Mn
Dec 31, 2025 222.00 Mn
Sep 30, 2025 225.00 Mn
Jun 30, 2025 247.00 Mn
Mar 31, 2025 276.00 Mn
Dec 31, 2024 369.00 Mn
Sep 30, 2024 430.00 Mn
Jun 30, 2024 461.00 Mn
Mar 31, 2024 442.00 Mn
Dec 31, 2023 338.00 Mn
Sep 30, 2023 399.00 Mn
Jun 30, 2023 751.00 Mn
Mar 31, 2023 1.57 Bn
Dec 31, 2022 2.17 Bn
Sep 30, 2022 2.88 Bn
Jun 30, 2022 3.03 Bn
Mar 31, 2022 3.81 Bn
Dec 31, 2021 4.50 Bn
API Access

Bristol Myers Squibb Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=BMY&period=max&api_key=YOUR_API_KEY